Innovating Works
ReSpire: Respirable Advanced Therapeutics for Cystic Fibrosis other Lung Diseases OMNISPIRANT LIMITED tramitó un H2020: H2020-EIC-SMEInst-2018-2020 Via the SME Instrument OmniSpirant Ltd will mature its stem cell exosome-packaged gene therapy with lung mucus penetration properties which...
2019-01-28 - 2019-07-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.